Moloney Securities Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Moloney Securities Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$1.06 - $1.67 $63,600 - $100,200	-60,000 Reduced 75.0%	20,000 $23,000
Q2 2023 Jul 31, 2023	SELL	$1.14 - $1.95 $1,709 - $2,925	-1,500 Reduced 1.84%	80,000 $148,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.19 $20,551 - $37,505	-17,126 Reduced 17.36%	81,500 $108,000
Q4 2022 Jan 30, 2023	BUY	$1.63 - $3.52 $52,365 - $113,083	32,126 Added 48.31%	98,626 $166,000
Q3 2022 Oct 31, 2022	BUY	$0.73 - $3.74 $48,545 - $248,710	66,500 New	66,500 $207,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.